Da32 Life Science Net Income

Da32 Life Science technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices.

Da32 Life's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Da32 Life's valuation are provided below:

Da32 Life Science does not today have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

No data is currently available for this entity. Please try again at a later time.

Search Suggestions

DAC	Danaos	Company
DAAIX	Dunham Appreciation Income	Mutual Fund
DAG	DWS	ETF
DAT	DAT	Cryptocurrency

Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Competition

Based on the recorded statements, Da32 Life Science reported net income of 599.22 K. This is 99.95% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The net income for all United States stocks is 99.9% higher than that of the company.

Da32 Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Da32 Life's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Da32 Life could also be used in its relative valuation, which is a method of valuing Da32 Life by comparing valuation metrics of similar companies.

Da32 Life is currently under evaluation in net income category among its peers.

Da32 Fundamentals

	Return On Asset	-0.0054
	Current Valuation	263.63 M
	Shares Outstanding	20.65 M
	Shares Owned By Insiders	7.02 %
	Shares Owned By Institutions	92.98 %
	Number Of Shares Shorted	1.87 K
	EBITDA	(4.66 M)
	Net Income	599.22 K
	Cash And Equivalents	1.1 M
	Cash Per Share	0.04 X
	Total Debt	200 K
	Current Ratio	8.61 X
	Book Value Per Share	(0.20) X
	Cash Flow From Operations	(1.1 M)
	Short Ratio	0.05 X
	Earnings Per Share	0.06 X
	Market Capitalization	264.2 M
	Total Asset	203.86 M
	Retained Earnings	(4.74 M)
	Working Capital	(121.07 K)
	Net Asset	203.86 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Da32 Stock

If you are still planning to invest in Da32 Life Science check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Da32 Life's history and understand the potential risks before investing.

	Fundamental Analysis View fundamental data based on most recent published financial statements
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC